When was Beike Biotech founded?

Beike Biotech was founded in 2005.

Where is Beike Biotech located?

Beike Biotech is headquartered in Shenzhen, China.

How many employees does Beike Biotech have?

As of May 31, 2026, the latest employee count at Beike Biotech is 41.

Where does Beike Biotech rank among its competitors?

Beike Biotech ranks 62nd amongst 211 active competitors, of which 30 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was BioLamina, which secured $23.6M in Apr, 2026.

Who are the top competitors of Beike Biotech?

Beike Biotech's top competitors include BioLife Solutions, Integrated DNA Technologies and RoosterBio. Among them, BioLamina secured the most recent funding round in April, 2026.

Beike Biotech - 2026 Company Profile, Team & Competitors

Company Details

Beike Biotech provides stem cells and specializes in the research, clinical translation, and technology support services of adult stem cells.

Website: beikebiotech.com
Social
Email ID: *****@beikebiotech.com
Phone Number: +86 **********

Key Metrics

Founded Year

2005

Location

Shenzhen, China

Stage

Unfunded

Ranked

62^nd among 211 active competitors

Employee Count

41 as on May 31, 2026

Similar Companies

BioLife Solutions & 276 more

View Beike Biotech's full profile

Beike Biotech has not raised any funding rounds yet.

Beike Biotech's employee count trend

Beike Biotech has 41 employees as of May 26. Here is Beike Biotech's employee count trend over the years:

Uncover Beike Biotech's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Beike Biotech include BioLife Solutions, Integrated DNA Technologies and RoosterBio. Here is the list of Top 10 competitors of Beike Biotech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	BioLife Solutions 1987, Bothell (United States), Acquired	Developer of cell and gene therapies with the integrity of a single cell	-	-	67/100
2nd	Integrated DNA Technologies 1987, Coralville (United States), Acquired	Provider of oligonucleotide-based reagents and kits	-	Summit Partners, Golub Capital & 1 others	63/100
3rd	RoosterBio 2012, Frederick (United States), Series B	Developer of human mesenchymal stem cells and extracellular vesicles	$38.4M	Planetary Technologies, Dynamk Capital & 4 others	57/100
4th	BioLamina 2008, Sundbyberg (Sweden), Series B	Cell culture reagents for stem cell research	$18.2M	Lauxera Capital Partners, Bure Equity & 5 others	56/100
5th	Acorn 2017, Toronto (Canada), Series A	Provider of stem cell biobanking services	$3.33M	TELUS Ventures, Accelerator Centre & 5 others	55/100
6th	StemCyte 1997, Covina (United States), Public	Cord blood banking and regenerative therapeutics company focused on saving lives	$23.3M	penbank.com, Montage Capital & 7 others	53/100
7th	Shanghai Doning Biotechnology 2005, Shanghai (China), Series C	Provider of cell culture media	$14.9M	HongShan, Ally Bridge Group & 1 others	51/100
8th	ArcticZymes 2009, Tromso (Norway), Public	Developer of recombinant enzymes from various arctic species	-	Europa, Northislet	49/100
9th	Toyobo 1882, New York City (United States), Public	Manufacturer of high performance materials including films and functional textiles	-	-	49/100
10th	Cryo-Cell 1989, Oldsmar (United States), Public	Provider of a cord blood bank to store stem cells	$2.9M	-	47/100
62nd	Beike Biotech 2005, Shenzhen (China), Unfunded	Stem cell provider	-	-	31/100